Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis
Ram P. Naikawadi, … , Mark R. Looney, Paul J. Wolters
Ram P. Naikawadi, … , Mark R. Looney, Paul J. Wolters
Published September 8, 2016
Citation Information: JCI Insight. 2016;1(14):e86704. https://doi.org/10.1172/jci.insight.86704.
View: Text | PDF
Resource and Technical Advance Pulmonology

Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis

  • Text
  • PDF
Abstract

Telomeres are short in type II alveolar epithelial cells (AECs) of patients with idiopathic pulmonary fibrosis (IPF). Whether dysfunctional telomeres contribute directly to development of lung fibrosis remains unknown. The objective of this study was to investigate whether telomere dysfunction in type II AECs, mediated by deletion of the telomere shelterin protein TRF1, leads to pulmonary fibrosis in mice (SPC-Cre TRF1fl/fl mice). Deletion of TRF1 in type II AECs for 2 weeks increased γH2AX DNA damage foci, but not histopathologic changes in the lung. Deletion of TRF1 in type II AECs for up to 9 months resulted in short telomeres and lung remodeling characterized by increased numbers of type II AECs, α-smooth muscle actin+ mesenchymal cells, collagen deposition, and accumulation of senescence-associated β-galactosidase+ lung epithelial cells. Deletion of TRF1 in collagen-expressing cells caused pulmonary edema, but not fibrosis. These results demonstrate that prolonged telomere dysfunction in type II AECs, but not collagen-expressing cells, leads to age-dependent lung remodeling and fibrosis. We conclude that telomere dysfunction in type II AECs is sufficient to cause lung fibrosis, and may be a dominant molecular defect causing IPF. SPC-Cre TRF1fl/fl mice will be useful for assessing cellular and molecular mechanisms of lung fibrosis mediated by telomere dysfunction.

Authors

Ram P. Naikawadi, Supparerk Disayabutr, Benat Mallavia, Matthew L. Donne, Gary Green, Janet L. La, Jason R. Rock, Mark R. Looney, Paul J. Wolters

×

Figure 4

Telomere dysfunction in fibroblasts causes lung edema.

Options: View larger image (or click on image) Download as PowerPoint
Telomere dysfunction in fibroblasts causes lung edema.
(A) Immunoblot sh...
(A) Immunoblot showing TRF1 expression in fibroblasts isolated from lungs of TRF1fl/fl and Col1a2-Cre TRF1fl/fl mice 2 days after injection of tamoxifen (250 mg/kg body weight). Lungs from 5 mice/group were pooled and fibroblasts isolated. (B) Survival of TRF1fl/fl and Col1a2-Cre TRF1fl/fl mice following injection of tamoxifen (250 mg/kg body weight). n = 10 mice/group, **P = 0.004, log-rank test. (C) Quantification of extravascular lung water 2 days after tamoxifen injection. *P < 0.05, 2-tailed Student’s t-test. (D and E) H&E-stained sections of lungs harvested from TRF1fl/fl and Col1a2-Cre TRF1fl/fl mice 2 days after tamoxifen injection. Note the pink edema fluid (arrows) in alveolar spaces of Col1a2-Cre TRF1fl/fl mice but not in TRF1fl/fl mice. Magnification: ×20. Scale bars: 100 μm. (F and G) H&E stained lung sections harvested from TRF1fl/fl and Col1a2-Cre TRF1fl/fl mice after 6 months of weekly tamoxifen injections. Scale bars: 100 μm. (H–J) Differential cell count of BALF obtained from TRF1fl/fl and Col1a2-Cre TRF1fl/fl mice 2 days after tamoxifen injection. There was no significant difference in the numbers of macrophages, PMNs, and lymphocytes between TRF1fl/fl and Col1a2-Cre TRF1fl/fl mice. n = 3–4 mice/group, P > 0.05, 2-tailed Student’s t-test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts